Clinical trial
Involvement of Endogenous Digitalis-like Compounds in Breast Cancer
NCT00310882 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00310882 |
|---|---|
| Title | Involvement of Endogenous Digitalis-like Compounds in Breast Cancer |
| Official title | Involvement of Endogenous Digitalis-like Compounds in Breast Cancer |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Breast Neoplasms, Fibrocystic Disease of Breast, Mammaplasty |
| Enrollment | 250 |
| Start date | May 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Apr 5, 2006 |
| Last update posted | Apr 8, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: